Classification
Product TypeIngredient
Product FormBulk ingredient (crystalline powder / oil concentrate)
Industry PositionNutraceutical and food-fortification ingredient
Market
Cholecalciferol (vitamin D3) in Mexico is primarily relevant as an input for finished oral dietary supplements and, depending on classification, other regulated health-related products. Mexico’s dietary supplement framework (suplementos alimenticios) allows products in oral dosage forms and governs acceptable composition, labeling, and advertising boundaries. Market access risk is driven less by agronomic seasonality and more by regulatory classification, compliant labeling/claims, and documentation quality at import and commercialization. Pharmacopeial quality expectations may apply where the product is treated as an input for health products, with FEUM providing mandatory analytical and quality references for regulated establishments.
Market RoleDomestic consumer market supplied via imported ingredient channels (trade balance not specified in this record)
Domestic RoleFormulation and packaging input for finished oral dietary supplements (suplementos alimenticios) and related regulated products
Specification
Physical Attributes- Quality control expectations are typically expressed through identity/purity/assay testing aligned to recognized pharmacopeial methods where applicable (e.g., FEUM in Mexico for regulated establishments).
Compositional Metrics- Assay (potency) and impurity profile are key release parameters for vitamin ingredients used in regulated products; specific numeric limits are not stated in this record.
Grades- Regulatory classification-dependent grade expectations (e.g., supplement ingredient vs. health-input category) may affect testing and documentation requirements.
Packaging- Importers commonly require batch/lot documentation (e.g., supplier certificate of analysis) and packaging suitable for maintaining declared quality through distribution (specific formats not stated in this record).
Supply Chain
Value Chain- Overseas ingredient manufacturer → bulk packaging → international freight → Mexican customs clearance (pedimento with e-documents) → importer/distributor → domestic supplement/food manufacturer → finished product labeling and commercialization controls
Temperature- Follow supplier-recommended storage and handling controls to protect declared quality; specific temperature setpoints are not stated in this record.
Shelf Life- Shelf-life and potency retention depend on storage conditions and packaging integrity; specific shelf-life durations are not stated in this record.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighMisclassification or non-compliance with Mexico’s sanitary framework for dietary supplements (e.g., prohibited therapeutic/disease claims, or formulations treated as health inputs due to pharmacological action) can block commercialization and trigger enforcement actions or product holds.Confirm product category early (supplement vs. health input), maintain a compliant label/claims dossier, and align formula/marketing materials to the dietary supplement provisions in Mexico’s sanitary regulation framework before import and sale.
Documentation Gap MediumIncomplete or inconsistent electronic annex documentation for the import pedimento (e.g., value document or transport document data issues) can delay customs clearance and disrupt manufacturing timelines.Run a pre-shipment documentation audit with the customs broker; ensure e-document transmission and pedimento identifiers match the commercial documents and transport records.
Labeling And Claims MediumFinished products containing vitamin D3 marketed as dietary supplements face compliance risk if labeling or promotional materials imply disease treatment/prevention or otherwise mislead about effects, composition, or nutritional substitution.Implement internal review for Spanish-language labeling and advertising claims against the dietary supplement labeling/advertising restrictions before market launch.
FAQ
What is the key Mexico-specific regulatory risk when selling vitamin D3 products as dietary supplements?Mexico’s dietary supplement rules restrict what you can claim on labels and marketing: supplements must not present therapeutic or disease-related indications, and products framed as having pharmacological action may be treated under different “health input” rules. This makes correct classification and compliant claims the main Mexico-specific blocker risk.
What customs documentation is commonly transmitted electronically with Mexico’s import pedimento for ingredient shipments?Mexico’s customs authority indicates that the commercial-value document (e.g., CFDI or equivalent invoice/value document) and the transport document (e.g., bill of lading/air waybill) are transmitted electronically as annexes to the import pedimento, along with evidence for non-tariff compliance and origin documentation when applicable. Missing or inconsistent data can cause clearance delays.